Autopsy report · NCT00612677

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

“slow accrual - the 1 patient accrued did not go on treatment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months after it had already started.
• Ran for about 7 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 3 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Sponsor type

University, hospital or other

Conditions

Lung Cancer

Interventions

Oxaliplatin; Pemetrexed

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
  “Due to slow accrual of patients” (73% match in meaning)
• Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
  “poor patient accrual” (73% match in meaning)
• Abiraterone-Rechallenge Study for CRPC Patients
  “Lack of Patient accrual” (69% match in meaning)
• SOX as Salvage Treatment in Nasopharyngeal Carcinoma
  “poor accrual of eligible patients” (69% match in meaning)
• Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
  “Inadequate patient accrual” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.